Compare XRAY & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XRAY | HTFL |
|---|---|---|
| Founded | 1899 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 1987 | 2025 |
| Metric | XRAY | HTFL |
|---|---|---|
| Price | $12.79 | $31.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $14.50 | ★ $39.50 |
| AVG Volume (30 Days) | ★ 4.1M | 786.5K |
| Earning Date | 02-26-2026 | 03-27-2026 |
| Dividend Yield | ★ 5.03% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,624,000,000.00 | $161,881,000.00 |
| Revenue This Year | N/A | $40.42 |
| Revenue Next Year | $0.75 | $22.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 85.70 |
| 52 Week Low | $9.85 | $25.38 |
| 52 Week High | $20.60 | $41.22 |
| Indicator | XRAY | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 60.67 | 46.51 |
| Support Level | $12.52 | $32.80 |
| Resistance Level | $13.03 | $35.98 |
| Average True Range (ATR) | 0.47 | 2.18 |
| MACD | 0.04 | -0.32 |
| Stochastic Oscillator | 80.93 | 12.16 |
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.